Duration of symptom control following intratympanic dexamethasone injections in Meniere's disease. Hilton A, McClelland A, McCallum R, Kontorinis G, et al. Eur Arch Otorhinolaryngol 2022 Apr 10. pii: 10.1007/s00405-022-07368.

Read + Share

Amedeo Smart

Independent Medical Education

Hilton A, McClelland A, McCallum R, Kontorinis G, et al. Duration of symptom control following intratympanic dexamethasone injections in Meniere's disease. Eur Arch Otorhinolaryngol 2022 Apr 10. pii: 10.1007/s00405-022-07368.
PMID: 35397703